Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesOncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction
Experimental Lung Research, 11/09/09
Simpson JL et al. – Oncostatin M mRNA expression and protein levels were significantly higher in the sputum of asthmatics with irreversible airflow obstruction. Sputum oncostatin M levels were highest in people with severe airflow obstruction and were localized to airway neutrophils and macrophages. Peripheral blood neutrophils released more oncostatin M when stimulated with lipopolysaccharide compared with unstimulated neutrophils. Sputum oncostatin M is increased in asthma with irreversible airflow obstruction and is present in airway neutrophils and macrophages. Oncostatin M may link airway inflammation to remodeling in asthma.
Today in Asthma/Atopy...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-inflammatory drug therapy in asthma
Paediatric Respiratory Reviews, 11/02/09
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Sponsor
Article Search
Sponsor